Proton beam radiation therapy, long used in cancer care, has produced an approximately 80% reduction in dangerous ventricular ...

Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...

Patients in the study had advanced heart failure and remained at risk for complications related to their underlying disease.

For patients with breast cancer, the journey toward survivorship often involves a delicate balancing act: delivering powerful ...

Texas Center for Proton Therapy has been serving cancer patients in Dallas-Fort Worth and beyond for nearly a decade. The 63,000-square-foot facility located in Irving is one of approximately 45 ...

Stanford Medicine opened a facility on Tuesday providing proton therapy to cancer patients. The treatment offers a new radiotherapy option previously unavailable in Northern California. Proton therapy ...

Phase 2 study shows proton therapy kept 79.1% of patients progression free at five years and limited severe side effects compared with older radiation data. Investigators at Mass General Brigham ...

Rising capacity, cost advantage, and new centres position India as a key destination for advanced cancer care, though access ...

A Mayo Clinic-led first-in-human study found that proton beam therapy, a cancer treatment technology, cut episodes of life-threatening ventricular tachycardia by nearly 80% in patients with no ...

This year, the Texas Center for Proton Therapy celebrates a decade of serving cancer patients across Dallas–Fort Worth and beyond. The 63,000-square-foot Irving facility is one of fewer than 50 proton ...

Huntsman Cancer Institute at the University of Utah (the U) is excited to announce the expansion of its Senator Orrin G. Hatch Proton Therapy Center, doubling its treatment capacity and increasing ...

The Total Body MRI at Ackerman Cancer Center. Read full article: Understanding breast cancer screenings: When to start, symptoms to watch for, and the role of advanced mammography Dr. Scot Ackerman.